80 related articles for article (PubMed ID: 10323463)
1. Interferon-alpha may exacerbate cryoblobulinemia-related ischemic manifestations: an adverse effect potentially related to its anti-angiogenic activity.
Cid MC; Hernández-Rodríguez J; Robert J; del Río A; Casademont J; Coll-Vinent B; Grau JM; Kleinman HK; Urbano-Márquez A; Cardellach F
Arthritis Rheum; 1999 May; 42(5):1051-5. PubMed ID: 10323463
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
3. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.
Zuckerman E; Keren D; Slobodin G; Rosner I; Rozenbaum M; Toubi E; Sabo E; Tsykounov I; Naschitz JE; Yeshurun D
J Rheumatol; 2000 Sep; 27(9):2172-8. PubMed ID: 10990230
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection.
La Civita L; Zignego AL; Lombardini F; Monti M; Longombardo G; Pasero G; Ferri C
J Rheumatol; 1996 Sep; 23(9):1641-3. PubMed ID: 8877939
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
Hauser P
Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
[TBL] [Abstract][Full Text] [Related]
6. Mixed cryoglobulinemia and hepatitis C virus infection.
Lunel F; Musset L
Minerva Med; 2001 Feb; 92(1):35-42. PubMed ID: 11317137
[TBL] [Abstract][Full Text] [Related]
7. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
Lunel F; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
[TBL] [Abstract][Full Text] [Related]
8. [Membranoproliferative glomerulonephritis in patients with cryoglobulinemia complicating hepatitis C virus: report of 11 cases].
Ben Fatma L; Ben Hamida F; Aoudia R; Goucha R; Kaaroud H; Béji S; Barbouch S; Hedri H; Abderrahim E; Elyounsi F; Ben Abdallah T; Ben Moussa F; Kheder A
Tunis Med; 2007 Mar; 85(3):220-4. PubMed ID: 17668578
[TBL] [Abstract][Full Text] [Related]
9. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
Ahmed MS; Wong CF
J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus-associated type II mixed cryoglobulinemia vasculitis complicated with membranous proliferative glomerulonephritis.
Lo KY; Chen CY; Lee CS
Ren Fail; 2009; 31(2):149-52. PubMed ID: 19212913
[TBL] [Abstract][Full Text] [Related]
11. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study.
Caniatti LM; Tugnoli V; Eleopra R; Tralli G; Bassi R; De Grandis D
J Peripher Nerv Syst; 1996; 1(2):131-8. PubMed ID: 10975721
[TBL] [Abstract][Full Text] [Related]
12. [Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment].
Lidove O; Cacoub P; Hausfater P; Wechsler B; Frances C; Leger JM; Piette JC
Gastroenterol Clin Biol; 1999 Mar; 23(3):403-6. PubMed ID: 10384347
[TBL] [Abstract][Full Text] [Related]
13. Cerebral ischemic attack secondary to hepatitis C virus infection.
Cojocaru IM; Cojocaru M; Iacob SA; Burcin C
Rom J Intern Med; 2005; 43(3-4):255-60. PubMed ID: 16812984
[TBL] [Abstract][Full Text] [Related]
14. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response.
Landau DA; Saadoun D; Halfon P; Martinot-Peignoux M; Marcellin P; Fois E; Cacoub P
Arthritis Rheum; 2008 Feb; 58(2):604-11. PubMed ID: 18240235
[TBL] [Abstract][Full Text] [Related]
15. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
Zheng YH; He Y; Yang X; Gong GZ; Zhou HY; Zhang CY; Zhou W; Huang L; Ding PP; Li H
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):741-4. PubMed ID: 16248945
[TBL] [Abstract][Full Text] [Related]
16. Longterm efficacy of interferon-alpha for extrahepatic disease associated with hepatitis C virus infection.
Naarendorp M; Kallemuchikkal U; Nuovo GJ; Gorevic PD
J Rheumatol; 2001 Nov; 28(11):2466-73. PubMed ID: 11708420
[TBL] [Abstract][Full Text] [Related]
17. Interferon alpha and neuromuscular disorders.
Stübgen JP
J Neuroimmunol; 2009 Feb; 207(1-2):3-17. PubMed ID: 19171385
[TBL] [Abstract][Full Text] [Related]
18. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
[TBL] [Abstract][Full Text] [Related]
19. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
20. Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients.
Ferri C; Zignego AL; Longombardo G; Monti M; La Civita L; Lombardini F; Greco F; Mazzoni A; Pasero G; Gentilini P
Infection; 1993; 21(2):93-7. PubMed ID: 7684029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]